Atricure Stock Performance
| ATRC Stock | USD 36.95 0.82 2.17% |
AtriCure has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.57, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. AtriCure right now shows a risk of 3.36%. Please confirm AtriCure treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to decide if AtriCure will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AtriCure are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, AtriCure may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
| Begin Period Cash Flow | 84.3 M | |
| Total Cashflows From Investing Activities | 30.2 M |
AtriCure Relative Risk vs. Return Landscape
If you would invest 3,403 in AtriCure on November 1, 2025 and sell it today you would earn a total of 292.00 from holding AtriCure or generate 8.58% return on investment over 90 days. AtriCure is currently generating 0.1922% in daily expected returns and assumes 3.3584% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than AtriCure, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AtriCure Target Price Odds to finish over Current Price
The tendency of AtriCure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 36.95 | 90 days | 36.95 | about 59.46 |
Based on a normal probability distribution, the odds of AtriCure to move above the current price in 90 days from now is about 59.46 (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.57 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, AtriCure will likely underperform. Additionally AtriCure has an alpha of 0.0739, implying that it can generate a 0.0739 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). AtriCure Price Density |
| Price |
Predictive Modules for AtriCure
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AtriCure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AtriCure Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AtriCure is not an exception. The market had few large corrections towards the AtriCure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AtriCure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AtriCure within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | 1.57 | |
σ | Overall volatility | 3.30 | |
Ir | Information ratio | 0.03 |
AtriCure Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AtriCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AtriCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AtriCure had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Why Phibro Animal Health is a Top Value Stock for the Long-Term |
AtriCure Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AtriCure Stock often depends not only on the future outlook of the current and potential AtriCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AtriCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47 M | |
| Cash And Short Term Investments | 122.7 M |
AtriCure Fundamentals Growth
AtriCure Stock prices reflect investors' perceptions of the future prospects and financial health of AtriCure, and AtriCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AtriCure Stock performance.
| Return On Equity | -0.0611 | |||
| Return On Asset | -0.0265 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 1.84 B | |||
| Shares Outstanding | 49.72 M | |||
| Price To Earning | 33.47 X | |||
| Price To Book | 4.01 X | |||
| Price To Sales | 3.62 X | |||
| Revenue | 465.31 M | |||
| EBITDA | (18.53 M) | |||
| Cash And Equivalents | 118.45 M | |||
| Cash Per Share | 2.55 X | |||
| Total Debt | 76.53 M | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | 9.59 X | |||
| Cash Flow From Operations | 12.2 M | |||
| Earnings Per Share | (0.61) X | |||
| Total Asset | 609.33 M | |||
| Retained Earnings | (401.75 M) | |||
| Current Asset | 74.75 M | |||
| Current Liabilities | 31.59 M | |||
About AtriCure Performance
By analyzing AtriCure's fundamental ratios, stakeholders can gain valuable insights into AtriCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AtriCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AtriCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Atricure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 875 people.Things to note about AtriCure performance evaluation
Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AtriCure had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Why Phibro Animal Health is a Top Value Stock for the Long-Term |
- Analyzing AtriCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AtriCure's stock is overvalued or undervalued compared to its peers.
- Examining AtriCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AtriCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AtriCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AtriCure's stock. These opinions can provide insight into AtriCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |